Ibuprofen extended-release capsules

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects. It is a sustained-release dosage form that allows the drug to be gradually released in the body. Each dose can provide continuous pain relief for 12 hours.

Each tablet of this product contains 0.3g of ibuprofen, the main ingredient. The auxiliary materials are: sugar, starch, stearic acid, polyvinyl pyrrolidone.

Ibuprofen sustained-release capsules are sustained-release capsules containing white spherical pellets.

It is used to relieve mild to moderate pain such as headache, migraine, toothache, dysmenorrhea, joint pain, muscle pain, neuralgia, and also for fever caused by the common cold or influenza.

Oral administration: Adults, 1 tablet at a time, 2 times a day (morning and evening).

1. A small number of patients may experience nausea, vomiting, abdominal pain, diarrhea, constipation, flatulence, burning sensation in the stomach or mild indigestion, gastrointestinal ulcers and bleeding, elevated transaminase, headache, dizziness, tinnitus, blurred vision, nervousness, drowsiness, lower limb edema or sudden weight gain. 2. Rare rash, urticaria, and itching. Extremely rare severe skin allergic reactions, exfoliative dermatitis, Stevens-Johnson syndrome, or bullous skin diseases such as erythema multiforme and epidermal necrolysis. 3. Rare allergic nephritis, cystitis, nephrotic syndrome, renal papillary necrosis or renal failure, especially in long-term use, usually accompanied by elevated serum urea levels and edema. Rare bronchospasm and asthma aggravation. 4. Patients with a history of intestinal diseases such as ulcerative colitis and Crohn's disease may have their condition aggravated. 5. Extremely rare hematopoietic disorders (anemia, leukopenia, thrombocytopenia, pancytopenia, agranulocytosis, initial symptoms are: fever, sore throat, superficial oral ulcers, flu-like symptoms, severe fatigue, unexplained bruises or bleeding) or liver disease, liver failure, hepatitis. 6. Extremely rare severe allergic reactions, symptoms include: facial, tongue and throat edema, dyspnea, tachycardia, hypotension (anaphylactic reaction, angioedema or shock). 7. Edema, hypertension, fluid retention and cardiopulmonary failure have been reported with treatment with nonsteroidal anti-inflammatory drugs. 8. In patients with autoimmune diseases (such as systemic lupus erythematosus, mixed connective tissue disease), there have been individual cases of symptoms of aseptic meningitis during ibuprofen treatment, such as stiff neck, headache, nausea, vomiting, fever or confusion.

1. Patients who are allergic to other non-steroidal anti-inflammatory drugs are contraindicated. 2. Pregnant women and lactating women are contraindicated. 3. Asthma patients who are allergic to aspirin are contraindicated. 4. Patients with severe liver and kidney dysfunction or severe heart failure are contraindicated. 5. Patients who are taking other drugs containing ibuprofen or other non-steroidal anti-inflammatory drugs, including those taking drugs known to be specific cyclooxygenase-2 inhibitors. Unless recommended by a doctor. 6. Patients with a history of upper gastrointestinal bleeding or perforation related to the use of non-steroidal anti-inflammatory drugs are contraindicated. 7. Patients with active or previous history of peptic ulcer, gastrointestinal bleeding or perforation are contraindicated.

Precautions for children: Children must use under adult supervision. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: Elderly patients are prone to adverse reactions due to decreased liver and kidney function, so they should be used with caution or in a reduced dosage.

1. When this product is used together with other antipyretic, analgesic and anti-inflammatory drugs, it may increase gastrointestinal adverse reactions and may cause ulcers. 2. When this product is used together with anticoagulants such as heparin and dicoumarol (such as warfarin), it may lead to prolonged prothrombin time and increased bleeding tendency. 3. When this product is used together with digoxin, methotrexate and oral hypoglycemic drugs, it can increase the blood concentration of these drugs and should not be used together. 4. When this product is used together with furosemide (furanosemid), the latter's sodium excretion and antihypertensive effects are weakened; when used together with antihypertensive drugs, the latter's antihypertensive effect is also reduced. 5. There have been reports of interactions when ibuprofen is used in combination with aminoglycosides, glucocorticoids, antiplatelet drugs such as aspirin, cyclosporine, CYP2C9 inhibitors (such as voriconazole and fluconazole), diuretics, lithium, quinolones, zidovudine, and selective serotonin reuptake inhibitors. It should be used with caution or under the guidance of a physician. 6. Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Sealed storage

0.3 g

36 months

Sino-American Tianjin SmithKline and French Lab., Ltd.

• Founded in:

  1984-09-23

• Address:

  Chenglinzhuang Industrial Zone, Dongli District, Tianjin

• Tax NO.:

  9112011060055017XM

• Registered Funds:

  $29.94 million

• Email:

  Log in to view